Positive association of angiotensin II receptor blockers, not angiotensin-converting enzyme inhibitors, with an increased vulnerability to SARS-CoV-2 infection in patients hospitalized for suspected COVID-19 pneumonia

Positive association of angiotensin II receptor blockers, not angiotensin-converting enzyme inhibitors, with an increased vulnerability to SARS-CoV-2 infection in patients hospitalized for suspected COVID-19 pneumonia

Background Angiotensin-converting enzyme 2 is the receptor that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses for entry into lung cells. Because ACE-2 may be modulated by angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs), there is concer...

Full description

Bibliographic Details
Main Authors: Beressi, J.-P (Author), Bertrand, A. (Author), Cochet, H. (Author), de Tournemire, M. (Author), Georges, J.-L (Author), Gilles, F. (Author), Koukabi-Fradelizi, M. (Author), Laureana, C. (Author), Livarek, B. (Author), Monguillon, V. (Author), Pasqualini, M. (Author), Prevot, A. (Author), Prost, J.-F (Author), Roger, G. (Author), Saba, J. (Author), Soltani, J. (Author)
Format: Article
Language:English
Published: Public Library of Science 2021
Subjects:
adult
Adult
age
aged
Aged
Aged, 80 and over
angiotensin 2 receptor antagonist
Angiotensin II Type 2 Receptor Blockers
angiotensin receptor antagonist
Angiotensin-Converting Enzyme Inhibitors
Article
complication
controlled study
coronavirus disease 2019
COVID-19
dipeptidyl carboxypeptidase inhibitor
disease association
female
Female
gender
hospital patient
human
Humans
hypertension
Hypertension
infection risk
major clinical study
male
Male
middle aged
Middle Aged
mineralocorticoid antagonist
observational study
patient care
pneumonia
Pneumonia
polymerase chain reaction
Retrospective Studies
retrospective study
risk assessment
risk factor
Risk Factors
very elderly
virus pneumonia
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items